Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Moretta

Showing results (171-180 of 205) with videos related to

Pageof 21
Sort By:
Molecular Immunology|December 21, 2004
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysisDaniela Pende, Cristina Bottino, Roberta Castriconi, et al.
The Journal of Experimental Medicine|September 27, 2006
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infectionDomenico Mavilio, Gabriella Lombardo, Audrey Kinter, et al.
Blood|November 13, 2004
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)Daniela Pende, Grazia Maria Spaggiari, Stefania Marcenaro, et al.
Oncoimmunology|March 5, 2016
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceAlessandra Dondero, Fabio Pastorino, Mariella Della Chiesa, et al.
The Journal of Clinical Investigation|August 16, 2011
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunityEmilie Mamessier, Aude Sylvain, Marie-Laure Thibult, et al.
International Immunology|December 17, 2009
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissuesMariella Della Chiesa, Michela Falco, Silvia Parolini, et al.
Oncoimmunology|September 20, 2018
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptorSilvia Gaggero, Maurizio Bruschi, Andrea Petretto, et al.
European Journal of Immunology|April 8, 2017
Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patientsRaffaella Meazza, Michela Falco, Stefania Marcenaro, et al.
Blood|October 24, 2008
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificityDaniela Pende, Stefania Marcenaro, Michela Falco, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2005
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptorsC Andrew Stewart, Fanny Laugier-Anfossi, Frédéric Vély, et al.
Pageof 21

Showing results (171-180 of 205) with videos related to

Sort By:
Pageof 21
Molecular Immunology|December 21, 2004
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysisDaniela Pende, Cristina Bottino, Roberta Castriconi, et al.
The Journal of Experimental Medicine|September 27, 2006
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infectionDomenico Mavilio, Gabriella Lombardo, Audrey Kinter, et al.
Blood|November 13, 2004
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)Daniela Pende, Grazia Maria Spaggiari, Stefania Marcenaro, et al.
Oncoimmunology|March 5, 2016
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceAlessandra Dondero, Fabio Pastorino, Mariella Della Chiesa, et al.
The Journal of Clinical Investigation|August 16, 2011
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunityEmilie Mamessier, Aude Sylvain, Marie-Laure Thibult, et al.
International Immunology|December 17, 2009
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissuesMariella Della Chiesa, Michela Falco, Silvia Parolini, et al.
Oncoimmunology|September 20, 2018
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptorSilvia Gaggero, Maurizio Bruschi, Andrea Petretto, et al.
European Journal of Immunology|April 8, 2017
Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patientsRaffaella Meazza, Michela Falco, Stefania Marcenaro, et al.
Blood|October 24, 2008
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificityDaniela Pende, Stefania Marcenaro, Michela Falco, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2005
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptorsC Andrew Stewart, Fanny Laugier-Anfossi, Frédéric Vély, et al.
Pageof 21